secwatch.observer — SEC 8-K summary
======================================

Issuer:     Artiva Biotherapeutics, Inc. (ARTV)
CIK:        0001817241
Form:       8-K
Filed at:   2026-07-22T21:15:36+00:00
Accession:  0001193125-26-312560
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Artiva Biotherapeutics sets 2026 annual meeting for Sept 8; stockholder proposal deadline Aug 1
--------------------------------------------------------------------------------

- Annual meeting scheduled for September 8, 2026.
- Stockholder proposals and nominations due by close of business on August 1, 2026.
- Deadline applies to both business brought before meeting and director nominations.
- Rule 14a-8 proposals for proxy inclusion also due by August 1, 2026.
- Notices must be sent to Artiva's principal executive offices in San Diego.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/0001193125-26-312560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817241/000119312526312560/artv-20260722.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-312560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer